Results 51 to 60 of about 2,021,559 (378)

Characteristics of Heart Failure With Preserved Ejection Fraction Across the Range of Left Ventricular Ejection Fraction

Circulation, 2022
Background: Recent trial data suggest that stratification of patients with heart failure with preserved ejection fraction (HFpEF) according to left ventricular ejection fraction (LVEF) provides a means for dissecting different treatment responses ...
S. Rosch, Karl-Patrik Kresoja, C. Besler, K. Fengler, A. Schöber, M. von Roeder, C. Lücke, M. Gutberlet, K. Klingel, H. Thiele, K. Rommel, P. Lurz   +11 more
semanticscholar   +1 more source

What can we learn from SOCRATES: more questions than answers? [PDF]

, 2017
This editorial refers to ‘Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) Study’, by B ...
Cleland, John G.F., Mueller, Christian
core   +1 more source

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

New England Journal of Medicine, 2019
BACKGROUND The angiotensin receptor-neprilysin inhibitor sacubitril-valsartan led to a reduced risk of hospitalization for heart failure or death from cardiovascular causes among patients with heart failure and reduced ejection fraction.
S. Solomon, J. McMurray, I. Anand, J. Ge, C. Lam, A. Maggioni, F. Martinez, M. Packer, M. Pfeffer, B. Pieske, M. Redfield, J. Rouleau, D. V. van Veldhuisen, F. Zannad, M. Zile, Akshay S. Desai, Brian Claggett, P. Jhund, S. Boytsov, J. Comín-Colet, J. Cleland, H. Düngen, E. Goncalvesova, T. Katova, J. K. Kerr Saraiva, M. Lelonek, B. Merkely, M. Senni, Sanjiv J. Shah, Jingmin Zhou, A. Rizkala, J. Gong, V. Shi, M. Lefkowitz   +33 more
semanticscholar   +1 more source

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Circulation, 2021
Supplemental Digital Content is available in the text. Background: Patients with heart failure with preserved ejection fraction have significant impairment in health-related quality of life.
J. Butler, G. Filippatos, T. Jamal Siddiqi, M. Brueckmann, M. Böhm, V. Chopra, João Pedro Ferreira, J. Januzzi, S. Kaul, I. Piña, P. Ponikowski, Sanjiv J. Shah, M. Senni, O. Vedin, S. Verma, B. Peil, S. Pocock, F. Zannad, M. Packer, S. Anker   +19 more
semanticscholar   +1 more source

Heart failure with preserved ejection fraction [PDF]

Clinical Medicine, 2018
Heart failure with preserved ejection fraction (HFpEF) represents a heterogeneous collection of conditions that are unified by the presence of a left ventricular ejection fraction ≥50%, evidence of impaired diastolic function and elevated natriuretic peptide levels, all within the context of typical heart failure signs and symptoms.
Harper, AR, Patel, HC, Lyon, AR
openaire   +5 more sources

Rehabilitation outcomes of stroke patients with low left ventricular ejection fraction in the subacute rehabilitation phase

Journal of Rehabilitation Medicine, 2018
Objective: To examine the left ventricular ejection fraction in patients with subacute stroke and compare rehabilitation outcomes between those with decreased left ventricular ejection fraction and those without.
Masahiro Tsujikawa, Yohei Otaka, Rei Hasegawa, Kunitsugu Kondo, Kaori Muraoka, Meigen Liu   +5 more
doaj   +1 more source

Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry

Anatolian Journal of Cardiology, 2023
Background: Heart failure with preserved ejection fraction is a complex and heterogeneous clinical syndrome, poses significant diagnostic challenges.
Gurbet Özge Mert, Bülent Özlek, Eda Özlek, Hicaz Zencirkiran Ağuş, Mehmet Tekinalp, Serkan Kahraman, Cem Çil, Oğuzhan Çelik, Özcan Başaran, Volkan Doğan, Bedri Caner Kaya, İbrahim Rencüzoğulları, Altuğ Ösken, Lütfü Bekar, Mustafa Ozan Çakır, Yunus Çelik, Kadriye Memiç Sancar, Samet Sevinç, Murat Biteker, Kadir Uğur Mert   +19 more
doaj   +1 more source

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

European Heart Journal, 2019
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA-PEFF diagnostic algorithm'.
B. Pieske, C. Tschöpe, R. D. de Boer, A. Fraser, S. Anker, E. Donal, F. Edelmann, M. Fu, M. Guazzi, C. Lam, P. Lancellotti, V. Melenovský, D. Morris, E. Nagel, E. Pieske‐Kraigher, P. Ponikowski, S. Solomon, R. Vasan, F. Rutten, A. Voors, F. Ruschitzka, W. Paulus, P. Seferovic, G. Filippatos   +23 more
semanticscholar   +1 more source

Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone

BMC Medical Informatics and Decision Making, 2020
Background Cardiovascular diseases kill approximately 17 million people globally every year, and they mainly exhibit as myocardial infarctions and heart failures.
D. Chicco, Giuseppe Jurman
semanticscholar   +1 more source

Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction: A Substudy of the Empire HF Randomized Clinical Trial.

JAMA cardiology, 2021
Importance Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve outcomes in patients with heart failure and a reduced ejection fraction (HFrEF). The association with cardiac remodeling has not been investigated.
M. Omar, J. Jensen, Mulham Ali, P. Frederiksen, C. Kistorp, L. Videbæk, M. Poulsen, C. Tuxen, S. Möller, F. Gustafsson, L. Køber, M. Schou, J. Møller   +12 more
semanticscholar   +1 more source